Cargando…

PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications

Brain ischemia/reperfusion (I/R) injury (BI/RI) is a leading cause of death and disability worldwide. However, the outcome of pharmacotherapy for BI/RI remains unsatisfactory. Innovative approaches for enhancing drug sensitivity and recovering neuronal activity in BI/RI treatment are urgently needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Guangtao, Gu, Huan, Hu, Bo, Tong, Fei, Liu, Daojun, Yu, Xiaojun, Zheng, Yongxia, Gu, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367577/
https://www.ncbi.nlm.nih.gov/pubmed/28356740
http://dx.doi.org/10.2147/IJN.S130842
_version_ 1782517797858836480
author Xu, Guangtao
Gu, Huan
Hu, Bo
Tong, Fei
Liu, Daojun
Yu, Xiaojun
Zheng, Yongxia
Gu, Jiang
author_facet Xu, Guangtao
Gu, Huan
Hu, Bo
Tong, Fei
Liu, Daojun
Yu, Xiaojun
Zheng, Yongxia
Gu, Jiang
author_sort Xu, Guangtao
collection PubMed
description Brain ischemia/reperfusion (I/R) injury (BI/RI) is a leading cause of death and disability worldwide. However, the outcome of pharmacotherapy for BI/RI remains unsatisfactory. Innovative approaches for enhancing drug sensitivity and recovering neuronal activity in BI/RI treatment are urgently needed. The purpose of this study was to evaluate the protective effects of tumor necrosis factor (TNF)-α-loaded poly(ethylene glycol)-b-(poly(ethylenediamine L-glutamate)-g-poly(L-lysine)) (TNF-α/PEG-b-(PELG-g-PLL)) nanoparticles on BI/RI. The particle size of PEG-b-(PELG-g-PLL) and the loading and release rates of TNF-α were determined. The nanoparticle cytotoxicity was evaluated in vitro using rat cortical neurons. Sprague Dawley rats were preconditioned with free TNF-α or TNF-α/PEG-b-(PELG-g-PLL) polyplexes and then subjected to 2 hours ischemia and 22 hours reperfusion. Brain edema was assessed using the brain edema ratio, and the antioxidative activity was assessed by measuring the superoxide dismutase (SOD) activity and the malondialdehyde (MDA) content in the brain tissue. We further estimated the inflammatory activity and apoptosis level by determining the levels of interleukin-4 (IL-4), IL-6, IL-8, IL-10, and nitric oxide (NO), as well as the expression of glial fibrillary acidic protein (GFAP), intercellular adhesion molecule-1 (ICAM-1), and cysteine aspartase-3 (caspase-3), in the brain tissue. We provide evidence that TNF-α preconditioning attenuated the oxidative stress injury, the inflammatory activity, and the apoptosis level in I/R-induced cerebral injury, while the application of block copolymer PEG-b-(PELG-g-PLL) as a potential TNF-α nanocarrier with sustained release significantly enhanced the bioavailability of TNF-α. We propose that the block copolymer PEG-b-(PELG-g-PLL) may function as a potent nanocarrier for augmenting BI/RI pharmacotherapy, with unprecedented clinical benefits. Further studies are needed to better clarify the underlying mechanisms.
format Online
Article
Text
id pubmed-5367577
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53675772017-03-29 PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications Xu, Guangtao Gu, Huan Hu, Bo Tong, Fei Liu, Daojun Yu, Xiaojun Zheng, Yongxia Gu, Jiang Int J Nanomedicine Original Research Brain ischemia/reperfusion (I/R) injury (BI/RI) is a leading cause of death and disability worldwide. However, the outcome of pharmacotherapy for BI/RI remains unsatisfactory. Innovative approaches for enhancing drug sensitivity and recovering neuronal activity in BI/RI treatment are urgently needed. The purpose of this study was to evaluate the protective effects of tumor necrosis factor (TNF)-α-loaded poly(ethylene glycol)-b-(poly(ethylenediamine L-glutamate)-g-poly(L-lysine)) (TNF-α/PEG-b-(PELG-g-PLL)) nanoparticles on BI/RI. The particle size of PEG-b-(PELG-g-PLL) and the loading and release rates of TNF-α were determined. The nanoparticle cytotoxicity was evaluated in vitro using rat cortical neurons. Sprague Dawley rats were preconditioned with free TNF-α or TNF-α/PEG-b-(PELG-g-PLL) polyplexes and then subjected to 2 hours ischemia and 22 hours reperfusion. Brain edema was assessed using the brain edema ratio, and the antioxidative activity was assessed by measuring the superoxide dismutase (SOD) activity and the malondialdehyde (MDA) content in the brain tissue. We further estimated the inflammatory activity and apoptosis level by determining the levels of interleukin-4 (IL-4), IL-6, IL-8, IL-10, and nitric oxide (NO), as well as the expression of glial fibrillary acidic protein (GFAP), intercellular adhesion molecule-1 (ICAM-1), and cysteine aspartase-3 (caspase-3), in the brain tissue. We provide evidence that TNF-α preconditioning attenuated the oxidative stress injury, the inflammatory activity, and the apoptosis level in I/R-induced cerebral injury, while the application of block copolymer PEG-b-(PELG-g-PLL) as a potential TNF-α nanocarrier with sustained release significantly enhanced the bioavailability of TNF-α. We propose that the block copolymer PEG-b-(PELG-g-PLL) may function as a potent nanocarrier for augmenting BI/RI pharmacotherapy, with unprecedented clinical benefits. Further studies are needed to better clarify the underlying mechanisms. Dove Medical Press 2017-03-23 /pmc/articles/PMC5367577/ /pubmed/28356740 http://dx.doi.org/10.2147/IJN.S130842 Text en © 2017 Xu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Xu, Guangtao
Gu, Huan
Hu, Bo
Tong, Fei
Liu, Daojun
Yu, Xiaojun
Zheng, Yongxia
Gu, Jiang
PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
title PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
title_full PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
title_fullStr PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
title_full_unstemmed PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
title_short PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
title_sort peg-b-(pelg-g-pll) nanoparticles as tnf-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367577/
https://www.ncbi.nlm.nih.gov/pubmed/28356740
http://dx.doi.org/10.2147/IJN.S130842
work_keys_str_mv AT xuguangtao pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications
AT guhuan pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications
AT hubo pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications
AT tongfei pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications
AT liudaojun pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications
AT yuxiaojun pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications
AT zhengyongxia pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications
AT gujiang pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications